MORE VIDEOS
Mag-explore pa
Cancer sa suso

Susunod

Auto-play
NCI Minute: Study Finds Promising Results for Treating Anal Cancer in People Living with HIV
00:01:29
NCI Minute: Study Finds Promising Results for Treating Anal Cancer in People Living with HIV
15 Mga view . 03/09/25 administrator
Screening for Anal Cancer: When to Screen and What to Do With the Results
00:36:55
Screening for Anal Cancer: When to Screen and What to Do With the Results
2 Mga view . 10/15/23 administrator
Screening for Anal Cancer: When to Screen and What to Do With the Results
00:36:55
Screening for Anal Cancer: When to Screen and What to Do With the Results
1 Mga view . 10/15/23 administrator
DART desmoid tumor results: anti-CTLA-4 and anti-PD-1 blockade in rare tumors
00:02:00
DART desmoid tumor results: anti-CTLA-4 and anti-PD-1 blockade in rare tumors
2 Mga view . 09/10/23 administrator
Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
00:46:23
Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
5 Mga view . 09/10/23 administrator
Why Do Biopsy Results Take So Long? (How Long? Up to 7 Days)
00:06:12
Why Do Biopsy Results Take So Long? (How Long? Up to 7 Days)
0 Mga view . 09/10/23 administrator
What are “false-positive” results in cervical cancer screening?
00:09:03
What are “false-positive” results in cervical cancer screening?
2 Mga view . 09/10/23 administrator
Cone Biopsy Experience & Results | Cervical Cancer Screening
00:06:14
Cone Biopsy Experience & Results | Cervical Cancer Screening
4 Mga view . 09/10/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Mga view . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Mga view . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Mga view . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Mga view . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Mga view . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Mga view . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Mga view . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Mga view . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Mga view . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Mga view . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Mga view . 08/09/23 administrator

Cerdulatinib yields 'encouraging' results in CTCL, PTCL

4 Mga view • 08/09/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

The spleen tyrosine kinase/Janus kinase inhibitor cerdulatinib has demonstrated activity against relapsed and refractory T-cell lymphomas. In a phase 2 trial, cerdulatinib produced responses in 34% of patients with peripheral T-cell lymphoma (PTCL) and 26% of those with cutaneous T-cell lymphoma (CTCL). Learn more at www.mdedge.com/hematology-oncology.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play

NCI Minute: Study Finds Promising Results for Treating Anal Cancer in People Living with HIV
00:01:29
NCI Minute: Study Finds Promising Results for Treating Anal Cancer in People Living with HIV
15 Mga view . 03/09/25 administrator
Screening for Anal Cancer: When to Screen and What to Do With the Results
00:36:55
Screening for Anal Cancer: When to Screen and What to Do With the Results
2 Mga view . 10/15/23 administrator
Screening for Anal Cancer: When to Screen and What to Do With the Results
00:36:55
Screening for Anal Cancer: When to Screen and What to Do With the Results
1 Mga view . 10/15/23 administrator
DART desmoid tumor results: anti-CTLA-4 and anti-PD-1 blockade in rare tumors
00:02:00
DART desmoid tumor results: anti-CTLA-4 and anti-PD-1 blockade in rare tumors
2 Mga view . 09/10/23 administrator
Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
00:46:23
Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
5 Mga view . 09/10/23 administrator
Why Do Biopsy Results Take So Long? (How Long? Up to 7 Days)
00:06:12
Why Do Biopsy Results Take So Long? (How Long? Up to 7 Days)
0 Mga view . 09/10/23 administrator
What are “false-positive” results in cervical cancer screening?
00:09:03
What are “false-positive” results in cervical cancer screening?
2 Mga view . 09/10/23 administrator
Cone Biopsy Experience & Results | Cervical Cancer Screening
00:06:14
Cone Biopsy Experience & Results | Cervical Cancer Screening
4 Mga view . 09/10/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Mga view . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Mga view . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Mga view . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Mga view . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Mga view . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Mga view . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Mga view . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Mga view . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Mga view . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Mga view . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Mga view . 08/09/23 administrator